Peter Thériault Technical advisor

Peter Thériault Technical advisor

Office

  • Montréal

Phone number

514 877-3005

Languages

  • English
  • French

Profile

Peter is a technical advisor in Lavery’s Intellectual Property group.

With over a decade of varied experience in the life sciences, he has cultivated deep expertise in the development and protection of healthcare sector innovations.

During his eclectic career, Peter has worked in academic research administration, in pharmaceutical industry R&D, and for contract research organizations (CRO). More specifically, he has consulted on both intellectual property issues and scientific questions. His experience has allowed him to develop a wide range of technical and professional skills, which he has channeled into complex projects in the healthcare sector. 

He also received many awards and scholarships during his academic career.

Peter is recognized by his peers as an ambassador of progress in the healthcare sector, leveraging his passion for innovation in the life sciences.

 

Publications

  • Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression. Brain, Behavior and Immunity 99:363-382, 2022
  • Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monocytes with Patrolling Properties. Cell Reports 20(8):1830-1843, 2017
  • High fat diet exacerbates Alzheimer’s disease-related pathology in APPswe/PS1 mice. Oncotarget, 2016
  • Senescence impairs myelin debris clearance. Current biology 16, 772–775, 2016
  • Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner. Oncotarget, 2016
  • Isolation and purification of murine microglial cells for flow cytometry. Bio-Protocol 6-1, 2016
  • Recombinant tissue-plasminogen activator attenuates the development of Alzheimer's disease-related pathology in APPswe/PS1 mice. Neuropsychopharmacology 1-38, 2015
  • The dynamics of monocytes and microglia in Alzheimer's disease. Alzheimer's research and therapy 7-41, 2015
  • The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders. International Journal of Molecular Sciences, 2014
  • Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation. Acta Neuropathologica Communications 1-75, 2013
  • Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proceedings of the National Academy of Sciences 110, 1941–1946, 2013
  • Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behavioural Brain Research 234, 334–342, 2012

Education

  • PhD, Molecular Medicine, Université Laval, 2017
  • MSc, Physiology and Endocrinology, Université Laval, 2012
  • BSc, Biotechnology, Université de Sherbrooke, 2010
  1. Lavery Welcomes Peter Thériault to its Intellectual Property Group

    We are pleased to welcome Peter Thériault as Technical Advisor in Lavery's Intellectual Property group. With over a decade of varied experience in the life sciences, he has cultivated deep expertise in the development and protection of healthcare sector innovations. During his eclectic career, Peter has worked in academic research administration, in pharmaceutical industry R&D, and for contract research organizations (CROs). More specifically, he has consulted on both intellectual property issues and scientific questions. His experience has allowed him to develop a wide range of technical and professional skills, which he has channelled into complex projects in the healthcare sector. "I have always believed in the need to contribute to innovation in the healthcare sector for the benefit of all. That conviction turned into a passion for life sciences during my academic career. Since completing my studies, I have been eager to put this passion to good use, somewhere where I could realize my full potential. I quickly fell under the spell of intellectual property, a fascinating field that is constantly evolving. As fellowship, excellence and leadership are core values, it seemed natural for me to join Lavery's Intellectual Property team to achieve my ambitions. I have now found my place here!" About LaveryLavery is the leading independent law firm in Québec. Its more than 200 professionals, based in Montréal, Québec City, Sherbrooke and Trois-Rivières, work every day to offer a full range of legal services to organizations doing business in Québec. Recognized by the most prestigious legal directories, Lavery professionals are at the heart of what is happening in the business world and are actively involved in their communities. The firm's expertise is frequently sought after by numerous national and international partners to provide support in cases under Québec jurisdiction.

    Read more